“…Based on the QUADAS-2 tool, 18 studies achieved a low risk rate on all domains, 2,[8][9][10][11]13,[15][16][17]19,20,23,[26][27][28][29]31,33 4 studies were evaluated as high risk 3,4,7,34 and 5 with unclear risk 1,6,30,32,35 in patient selection domain. Within Index test domain, 4 had high risk 4,14,21,25 while 1 was with unclear risk.…”